Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/1999
06/09/1999EP0920872A1 Use of rosmarinus officinalis for treating various diseases
06/09/1999EP0920515A1 A NOVEL HUMAN mRNA EDITING ENZYME
06/09/1999EP0920507A2 Secreted proteins and polynucleotides encoding them
06/09/1999EP0920417A1 Il-8 receptor antagonists
06/09/1999EP0920306A2 Chemokine receptor antagonists and methods of use therefor
06/09/1999EP0920253A1 Il-8 receptor antagonists
06/09/1999EP0808157B1 Medicated tissue paper product
06/09/1999EP0784613B1 Colchicine derivatives and the therapeutical use thereof
06/09/1999EP0775103B1 Retinoic acid x-receptor ligands
06/09/1999EP0751932B1 Vitamin-d amide derivatives
06/09/1999EP0614456B1 1alpha,24(s)-dihydroxy vitamin d2, its formation and use
06/09/1999CN1219174A Inhibitors of protein farnesyl transferase
06/09/1999CN1218806A Sorbic acid vitamin C ester
06/09/1999CN1218802A Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine
06/09/1999CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition
06/09/1999CN1218680A Liquid for curing scald and burn and its preparing method
06/09/1999CN1218673A External use medicine for curing acne
06/09/1999CN1218672A Compound arnebia root paste for curing heat injury of human body and its preparing method
06/09/1999CN1218662A Health article for removing foot foulness
06/09/1999CN1218661A Cosmetics and medicine containing light stable ultraviolet filter agent
06/08/1999US5910609 Compounds
06/08/1999US5910513 Substituted benzyl derivatives of polyalkylene polyamines and their use in cosmetic and pharmaceutical compositions
06/08/1999US5910508 Novel compounds useful in modulating cellular hormone receptors; treating skin disorders such as acne, psoriasis
06/08/1999US5910497 Treating acne vulgaris
06/08/1999US5910490 Inhibition of membrane receptors for elastin which are involved in degradation of fibrous stroma of the connective tissue
06/08/1999US5910431 Polynucleotides encoding chemokine α-2
06/08/1999US5910311 Inhibiting photoperoxidation of unsaturated lipid by contacting with composition comprising non-photocatalytic metal oxide, tocopherol, metal-inactivating complexing agent
06/03/1999WO1999027167A1 Process for the production of protein fibres and products thereof
06/03/1999WO1999027111A1 Desaturase genes and their use
06/03/1999WO1999027103A1 Mammalian cytokine-like polypeptide-10
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999026945A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS
06/03/1999WO1999026929A1 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
06/03/1999WO1999026921A1 SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS
06/03/1999WO1999026909A2 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
06/03/1999WO1999026650A1 ribB
06/03/1999WO1999026646A1 ribA
06/03/1999WO1999026628A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour
06/03/1999WO1999026624A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhe and scours
06/03/1999WO1999026619A1 Skin rash prevention composition
06/03/1999WO1999026616A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
06/03/1999WO1999026611A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
06/03/1999WO1999026610A1 Skin care composition
06/03/1999WO1999026590A1 Composition for external use
06/03/1999WO1999013819A3 Composition and method for reducing stinging in skin
06/03/1999WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/03/1999CA2312000A1 Mammalian cytokine-like polypeptide-10
06/03/1999CA2311472A1 Desaturase genes and their use
06/03/1999CA2311129A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scours
06/03/1999CA2310773A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour
06/03/1999CA2310750A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
06/03/1999CA2310725A1 Process for the production of protein fibres and products thereof
06/03/1999CA2310401A1 Alpha-hydroxy, -amino and -halo derivatives of beta-sulfone hydroxamates as matrix metalloproteinase inhibitors
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/03/1999CA2309341A1 Substituted .beta.-alanine derivatives as cell adhesion inhibitors
06/03/1999CA2309204A1 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as .alpha.v.beta.3 antagonists
06/02/1999EP0919550A1 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
06/02/1999EP0918857A1 Human induced tumor protein
06/02/1999EP0918795A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
06/02/1999EP0918792A1 Dipeptide benzamidine as a kininogenase inhibitor
06/02/1999EP0918771A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
06/02/1999EP0918504A2 Genistein as a preventive against ultraviolet induced skin photodamage and cancer
06/02/1999EP0845036B1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/02/1999EP0625138B1 Novel amidine derivatives, their preparation and their use as medicaments with ltb4 antagonistic effect
06/02/1999CN1218456A Irreversible inhibitors of tyrosine kinases
06/02/1999CN1218403A Formulation for use in prevention of pathogen induced diseases including HIV and HSV
06/02/1999CN1218395A Buccal delivery system
06/02/1999CN1218387A Cosmetic composition for rejuvenation of skin without skin irratation
06/02/1999CN1218047A Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
06/01/1999US5908865 Chlorhexidine gluconate-containing, stabilized aqueous pharmaceutical preparations
06/01/1999CA2144127C Antiageing and antistaining composition for skin and use thereof
06/01/1999CA2141372C Stabilized cosmetic or dermatological composition containing several precursors of the same active ingredient, maximizing its release and its use
06/01/1999CA2094266C Aerosol formulations of beclomethasone-17,21-dipropionate
06/01/1999CA1340567C Heterocyclic amide derivatives
05/1999
05/27/1999WO1999025819A2 Antisense oligonucleotides against tenascin for treating vitiligo
05/27/1999WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
05/27/1999WO1999025693A1 Metalloproteinase inhibitors
05/27/1999WO1999025686A1 Cyclic amine derivatives and their use as drugs
05/27/1999WO1999025380A2 Methods and compositions for the treatment of psoriasis
05/27/1999WO1999025344A1 Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
05/27/1999WO1999025338A1 Pharmaceutical composition containing zafirlukast
05/27/1999WO1999025332A1 Composition with azelaic acid
05/27/1999WO1999025330A1 Treatment of scar tissue using lipoic acid
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/27/1999WO1999012933A3 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/27/1999DE19750702A1 Antisense oligonucleotides that bind to sequences encoding human tenascin for treating depigmentation, cancer, inflammation and cardiovascular disease
05/27/1999CA2310215A1 Methods and compositions for the treatment of psoriasis
05/27/1999CA2303961A1 Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
05/26/1999EP0917428A1 Hybrid matrix implants and explants
05/26/1999EP0804145A4 Oat oil compositions with useful dermatological properties
05/25/1999US5906812 Useful for treating intrisic and extrinsic aging such as wrinkles, fine lines, actinic blemishes, dyschromias, dermatitis or scars in human skin; cosmetics
05/20/1999WO1999024470A1 Mammalian milk growth factor
05/20/1999WO1999024469A1 Secreted proteins and polynucleotides encoding them
05/20/1999WO1999024423A1 Piperidine derivatives and their use as tachykinin antagonists
05/20/1999WO1999024419A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024416A1 Aminothiazole inhibitors of cyclin dependent kinases
05/20/1999WO1999024408A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/20/1999WO1999024404A1 Substituted pyridine compounds as anti-inflammatory agents
05/20/1999WO1999024399A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024398A2 Urea derivatives and their use as integrin inhibitors
1 ... 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 ... 1065